4th Quarter - Report
ALSTON & BIRD LLP for CELGENE CORPORATION
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription drugs in health care bills; orphan drug and rare disease bill; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment of 2013 (H.R. 460); MODDERN Cures Act (H.R. 3116); H.R. 5657, the FAST Generics Act of 2014; tax extenders package; 21st Century Cures; H.R. 5780, the Protecting the Integrity of Medicare Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| ROBERT J DOLE | — |
| DAN ELLING | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| PETER M KAZON | — |
| RUDY MISSMAR | — |
| MICHAEL PARK | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| MARC SCHEINESON | — |
| THOMAS A SCULLY | — |
| REGINA MARIA SHERICK | — |
| ROBERT SIGGINS | — |
| CAROLYN E SMITH | — |
| TIMOTHY P TRYSLA | — |
| MARILYN K YAGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.